Menu Search
Equities

LAVA Therapeutics NV

4PKB:STU

LAVA Therapeutics NV

Actions
  • Price (EUR)1.56
  • Today's Change-0.09 / -5.45%
  • Shares traded0.00
  • 1 Year change+13.87%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at LAVA Therapeutics NV fell by 56.10m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 38.97m for operations while cash used for investing totalled 17.64m.
Cash flow per share-0.8535
Price/Cash flow per share--
Book value per share1.63
Tangible book value per share1.63
More ▼

Balance sheet in USDView more

LAVA Therapeutics NV has a Debt to Total Capital ratio of 12.57%, a higher figure than the previous year's 2.06%.
Current ratio6.39
Quick ratio--
Total debt/total equity0.1437
Total debt/total capital0.1257
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.